Abstract：
Multiparametric Magnetic Resonance Imaging (MpMRI) and MRI-guided biopsy (MRGB) are the diagnostic gold standard in the management of men with suspicious prostate cancer (PCa). There are not enough studies, yet, that compare TRUS-MRGB, COG-TB and IB-MRGB. Despite IB-MRGB could be more accurate in detecting PCa in smaller lesions and a less operator dependent technique, there are still some concerns regarding high resource costs and the chance of missing lesions not visible at MRI or detected by systematic biopsy.
摘要：
多参数磁共振成像（MpMRI）和MRI引导活检（MRGB）是治疗可疑前列腺癌（PCa）男性的诊断金标准。没有足够的研究，然而，比较TRUS-MRGB，COG-TB和IB-MRGB。尽管IB-MRGB可以更准确地检测PCa在较小的病变和较少的操作者依赖的技术，对于高昂的资源成本以及在MRI上看不到或通过系统活检发现的缺失病变的可能性,仍然存在一些担忧.
